Medtronic Partners with 'King of Rigid Endoscopy' Karl Storz to Advance Integrated ENT Solutions

2026Year6Month4Day,Medtronic (NYSE：MDT) publicly announced that it would collaborate with KARL STORZ, known as the King of Rigid Endoscopy（Karl Storz）EstablishmentStrategic Collaboration: Joining Forces to Expand Access to Integrated ENT Surgical Solutions.

The two companies aim to, through MedtronicAiBLEENT Ecosystem, Driving a More Connected and Smarter Approach to Sinus Care. Medtronic'sAiBLE The intelligent ecosystem not only features an innovative robotic navigation system, but also encompasses data curation, artificial intelligence, imaging software, and related implants.

Medtronic plans to integrate its sinus surgery solutions andKarl Storz for comprehensive collaboration on the products ofThe scope of collaboration includes the item just obtained in MarchFDA ApprovedStealth AXiS Otorhinolaryngology Surgical System。Medtronic will provide its own solutions andKarl Storz Integrates endoscopy and visualization systems to help streamline the entire workflow in ENT operating rooms, from assessment and procurement to implementation.

The two companies also plan to engage in close collaboration by jointly conducting medical education programs.。These initiatives will be carried out through specialty training courses, educational content, and industry conferences, enabling surgeons tocan be obtained simultaneouslyPractical operational experience with these two techniques.

Dan, Vice President of Global Markets for Medtronic's ENT Business· Mendelson stated:

“This collaboration aims to make it easier for customers to integrate appropriate technologies into the operating room. By working with”KARL STORZ“By working together, we are building a more interconnected ENT surgical ecosystem and expanding access to solutions that support high-quality patient care.”

Karl Storz Vice President, Endoscopy Sales & Marketing, USChris SmithIndications:

“Through decades of innovation and trusted collaboration with clinicians, we have jointly driven the evolution of sinus and nasal mucosa care. Our partnership enables tighter integration of expertise, delivering more unified end-to-end solutions while further focusing on the needs of end-users in clinical settings.”